Tomoko Miyake

16PUBLICATIONS
39CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Gene and molecular therapyPredictive and prognostic markersEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 23, 2025
An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients with Adult T-Cell Leukemia/Lymphoma.

Kentaro Yonekura, Ikko Muto, Motoi Takenaka

|Jun 19, 2024
The treatment effect of endovascular therapy for chronic limb-threatening ischemia with systemic sclerosis.

Yoshihiro Matsuda, Tomoko Miyake, Hironobu Toda

|Jun 14, 2024
Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma.

Yoji Hirai, Jun Sakurai, Shiho Yoshida

|Apr 23, 2021
Multifunctionality of CD8+ T cells and PD-L1 expression as a biomarker of anti-PD-1 antibody efficacy in advanced melanoma.

Keiko Manabe, Osamu Yamasaki, Yuki Nakagawa

|Apr 08, 2020
The aim of the measurement of Epstein-Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites.

Tomoko Miyake, Keiji Iwatsuki, Yoji Hirai

Pageof 3

Frequent Collaborators

12 joint publications

Shin Morizane

9 joint publications

Yoshio Kawakami

8 joint publications

Yoji Hirai

2 joint publications

Osamu Yamasaki